Rowan Cos. (RDC) Tops Q1 EPS by 29c

Rowan Cos. (NYSE: RDC) reported Q1 EPS of $0.99, $0.29 better than the analyst estimate of $0.70. Revenue for the quarter came in at $547 million versus the consensus estimate of $533.08 million.

On May 5, 2015, the Company amended and restated its revolving credit agreement to increase the borrowing capacity from $1.0 billion to $1.5 billion and to extend the maturity date by one year to January 23, 2020. Commitments during the final year of the agreement decline by $60 million to $1.44 billion.

For earnings history and earnings-related data on Rowan Cos. (RDC) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c